These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


255 related items for PubMed ID: 7841300

  • 41. Normal plasmic cleavage of the gamma-chain variant of "fibrinogen Saga" with an Arg-275 to His substitution.
    Yamazumi K, Terukina S, Onohara S, Matsuda M.
    Thromb Haemost; 1988 Dec 22; 60(3):476-80. PubMed ID: 2976995
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. A new genetic fibrinogen variant (fibrinogen Erfurt I). Structurally characterized by an abnormal B beta-chain and present both in plasma and platelets.
    Meyer M, Schellenberg I, Vogel G, Bischoff I.
    Thromb Haemost; 1988 Apr 08; 59(2):138-42. PubMed ID: 3388290
    [Abstract] [Full Text] [Related]

  • 48. Hereditary dysfibrinogenaemia: structural and functional studies on three fibrinogen variants.
    Meyer M, Vogel G, Gromnica-Ihle E, Schellenberg I, Ostermann G.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988 Apr 08; 115(4):499-502. PubMed ID: 2465961
    [Abstract] [Full Text] [Related]

  • 49. Recombinant γT305A fibrinogen indicates severely impaired fibrin polymerization due to the aberrant function of hole 'A' and calcium binding sites.
    Ikeda M, Kobayashi T, Arai S, Mukai S, Takezawa Y, Terasawa F, Okumura N.
    Thromb Res; 2014 Aug 08; 134(2):518-25. PubMed ID: 24968960
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. [Fibrinogen Bern II: hereditary fibrinogen variant with amino acid substitution of arginine replaced by histidine in position 16 of the A alpha chain].
    Rupp C, Sievi R, Furlan M, Beck EA.
    Schweiz Med Wochenschr; 1983 Oct 08; 113(40):1460-2. PubMed ID: 6648427
    [Abstract] [Full Text] [Related]

  • 56. Fibrinogen Milano. VI: A heterozygous dysfibrinogenemia (A alpha 16 Arg----His) with bleeding tendency.
    Bögli C, Cofrancesco E, Cortellaro M, Della Volpe A, Hofer A, Furlan M, Zanussi C.
    Eur J Haematol; 1990 Jul 08; 45(1):26-30. PubMed ID: 2379562
    [Abstract] [Full Text] [Related]

  • 57. Molecular basis for fibrinogen Dusart (A alpha 554 Arg-->Cys) and its association with abnormal fibrin polymerization and thrombophilia.
    Koopman J, Haverkate F, Grimbergen J, Lord ST, Mosesson MW, DiOrio JP, Siebenlist KS, Legrand C, Soria J, Soria C.
    J Clin Invest; 1993 Apr 08; 91(4):1637-43. PubMed ID: 8473507
    [Abstract] [Full Text] [Related]

  • 58. Aberrant hepatic processing causes removal of activation peptide and primary polymerisation site from fibrinogen Canterbury (A alpha 20 Val --> Asp).
    Brennan SO, Hammonds B, George PM.
    J Clin Invest; 1995 Dec 08; 96(6):2854-8. PubMed ID: 8675656
    [Abstract] [Full Text] [Related]

  • 59. Abnormal fibrinogen Zlín (γThr21Ile) with missense mutation causing hypofibrinogenemia.
    Riedelová-Reicheltová Z, Riedel T, Májek P, Kotlin R, Geierová V, Suttnar J, Dyr JE.
    Acta Haematol; 2014 Dec 08; 132(2):140-3. PubMed ID: 24556703
    [No Abstract] [Full Text] [Related]

  • 60. Fibrinogen Stony Brook II: partial characterization of a heterozygously transmitted peptide A anomaly.
    Galanakis DK, Hultin M.
    Blood Coagul Fibrinolysis; 1990 Oct 08; 1(4-5):567-70. PubMed ID: 2133235
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.